4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-24-000062
President CEO and Chairman sold 49,633 shares at an average $138.30 ($6,864,136)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SAYER KEVIN R · President CEO and Chairman
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-08 | Sale : show line 1 in the form 10b5-1 | −27,272 | $137.96 | $3,762,489 | 306,254 | D |
| 2024-04-08 | Sale : show line 2 in the form 10b5-1 | −22,361 | $138.71 | $3,101,647 | 283,893 | D |
| Open-market sales · 49,633 sh · avg $138.30 · $6,864,136 | ||||||
Loading xslF345X05/edgardoc.xml…